1.201 - 1.225 of 56.863
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Moderna Call 28,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 1,79x
- Analysis
- Moderna Call 30,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 1,96x
- Analysis
- Oracle Call 190,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 2,46x
- Analysis
- Oracle Call 205,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 2,58x
- Analysis
- Oracle Call 220,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 2,69x
- Analysis
- Oracle Call 175,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 1,94x
- Analysis
- Oracle Call 220,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,12x
- Analysis
- Oracle Call 195,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,00x
- Analysis
- Novo Nordisk Call 390,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 3,01x
- Analysis
- Oracle Call 185,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 2,43x
- Analysis
- Oracle Call 170,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 2,33x
- Analysis
- Oracle Call 200,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 2,56x
- Analysis
- Oracle Call 195,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 2,53x
- Analysis
- Novo Nordisk Call 350,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,81x
- Analysis
- Oracle Call 175,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 2,36x
- Analysis
- Oracle Call 180,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 2,40x
- Analysis
- Novo Nordisk Call 370,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,87x
- Analysis
- Novo Nordisk Call 310,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,59x
- Analysis
- Novo Nordisk Call 400,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 3,01x
- Analysis
- Novo Nordisk Call 260,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,30x
- Analysis
- Novo Nordisk Call 330,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,70x
- Analysis
- Novo Nordisk Call 250,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,24x
- Analysis
- Novo Nordisk Call 340,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,76x
- Analysis
- Novo Nordisk Call 300,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,56x
- Analysis
- Oracle Call 190,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,01x
- Analysis